ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

NCI, ACS Agree On Interim Mammography Guides Dropping Routine Use for Women Under Age 50

August 27, 1976

Book Review: In Memoir Written to Avoid Doing Time, Disgraced Exec Reflects on BMS Heyday

July 6, 2012

Oxaliplatin Regimen May Beat Standard For Advanced Colorectal Cancer, NCI Says

April 26, 2002

Hormonal Therapy Improves Prostate Cancer Survival

August 27, 2004

Funding Opportunities Listed.

January 14, 2005